Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.42%
1,096.78
-4.59
-0.42%
—1,101.371,103.631,103.631,091.41——
SIXC
Communications
SIXC
Communications
SIXC
-1.39%
605.06
-8.29
-1.39%
—613.35613.35613.35604.38——
SIXE
Energy
SIXE
Energy
SIXE
-0.71%
1,190.29
-8.54
-0.71%
—1,198.831,199.681,199.751,187.98——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.83%
1,741.44
-14.51
-0.83%
—1,755.951,754.061,756.031,738.88——
SIXM
Financials
SIXM
Financials
SIXM
-0.44%
635.74
-2.77
-0.44%
—638.51637.41637.41633.05——
SIXR
Staples
SIXR
Staples
SIXR
+0.26%
845.51
+1.99
+0.26%
—843.52843.35846.40840.16——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.10%
216.17
+0.22
+0.10%
—215.95215.95216.52215.25——
SIXT
Technology
SIXT
Technology
SIXT
+1.58%
3,188.42
+49.51
+1.58%
—3,138.913,189.303,208.543,174.76——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.07%
935.07
+0.70
+0.07%
—934.37934.72936.04927.50——
SIXV
Health care
SIXV
Health care
SIXV
-1.09%
1,461.38
-16.05
-1.09%
—1,477.431,474.121,474.121,456.42——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.22%
2,384.47
+4.28
+0.22%
—2,380.192,389.342,396.912,380.47——
Q1 2026 earnings • in 5 days
See details
KLBF:IDX
Kalbe Farma Tbk PT
IDR 875.00
-3.85%
(-35.00) 1D
Apr 24, 4:14:27 PM GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for KLBF...
Open
IDR 910
High
IDR 915
Low
IDR 860
Mkt. cap
40.96T
Avg. vol.
41.13M
Volume
96.85M
Dividend
4.11%
Quarterly dividend
IDR 9
Ex dividend date
Jun 4, 2025
P/E ratio
10.87
52-wk high
IDR 1,600
52-wk low
IDR 860
EPS
IDR 81
Shares outstanding
46.88B
No. of employees
13K
News stories
From sources across the web
Profile
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise. The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient. Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar. Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
About Kalbe Farma Tbk PT
CEO-
Employees12.8K
FoundedSep 10, 1966
Headquarters-
SectorPharmaceutical industry
Websitekalbe.co.id
Next call in 5 days
Tue, Apr 28, 10:30 PM
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ (20.91 est.)IDR
Revenue / Estimate
-/ (9.66T est.)IDR
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Previous reportsAll values in IDR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in IDR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
8.85T
8.23T
8.91T
9.34T
Cost of goods sold
5.22T
4.94T
5.46T
5.92T
Cost of revenue
5.22T
4.94T
5.46T
5.92T
Research and development expenses
103.54B
136.97B
98.31B
160.88B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.14T
2.10T
2.51T
1.95T
Operating expense
2.24T
2.24T
2.60T
2.14T
Total operating expenses
7.46T
7.17T
8.06T
8.05T
Operating income
1.39T
1.06T
851.77B
1.28T
Other non operating income
-3.62B
-3.97B
-3.78B
-4.17B
EBT including unusual items
1.44T
1.19T
877.87B
1.30T
EBT excluding unusual items
1.44T
1.11T
888.55B
1.30T
Income tax expense
328.49B
275.47B
211.19B
252.81B
Effective tax rate
22.83%
23.09%
24.06%
19.41%
Other operating expenses
-4.39B
4.75B
-7.23B
31.35B
Net income
1.08T
898.17B
656.41B
1.03T
Net profit margin
12.17%
10.91%
7.37%
11.07%
Earnings per share
23.57
19.78
14.44
22.72
Interest and investment income
50.44B
47.01B
41.31B
40.43B
Interest expense
-9.40B
-10.38B
-9.69B
-5.77B
Net interest expenses
41.04B
36.63B
31.62B
34.66B
Depreciation and amortization charges
-
-
-
-
EBITDA
1.57T
1.26T
1.05T
1.47T
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer